Variables | Total study Population n = 1192 | Low C-NLR n = 596 | High C-NLR n = 596 | p value |
---|---|---|---|---|
Basic characteristics | ||||
Sex, male, % | 740(62.1) | 358(60.1) | 382(64.1) | 0.152 |
Age, years | 66.82 ± 12.52 | 64.97 ± 12.47 | 68.68 ± 12.31 | < 0.001 |
BMI, kg/m2 | 23.01 ± 3.80 | 23.03 ± 3.91 | 23.00 ± 3.70 | 0.882 |
SBP, mmHg | 122.05 ± 22.96 | 123.19 ± 22.79 | 120.91 ± 23.08 | 0.086 |
DBP, mmHg | 76.19 ± 15.05 | 77.09 ± 15.41 | 75.30 ± 14.64 | 0.041 |
HR, | 85.27 ± 21.03 | 82.69 ± 19.73 | 87.85 ± 21.96 | < 0.001 |
beat/minute | ||||
Smoking, % | 407(34.1) | 191(32.0) | 216(36.2) | 0.127 |
NYHA IV, % | 442(37.1) | 187(31.4) | 255(42.8) | < 0.001 |
Aetiologies | ||||
Coronary disease, % | 616(51.7) | 284(47.7) | 332(55.7) | 0.005 |
Hypertension, % | 658(55.2) | 326(54.7) | 332(55.7) | 0.727 |
Diabetes, % | 340(28.5) | 151(25.3) | 189(31.7) | 0.015 |
Peripheral vascular disease, % | 376(31.5) | 174(29.2) | 202(33.9) | 0.081 |
Atrial fibrillation, % | 405(34.0) | 204(34.2) | 201(33.7) | 0.854 |
Laboratory data | ||||
RBC, 10^12/L | 4.54 ± 0.76 | 4.60 ± 0.72 | 4.48 ± 0.80 | 0.005 |
WBC, 10^9/L NEU, 10^9/L | 7.96 ± 3.84 5.55 ± 3.36 | 6.79 ± 2.64 4.30 ± 2.01 | 9.12 ± 4.46 6.80 ± 3.93 | < 0.001 < 0.001 |
LYM, 10^9/L | 1.50 ± 0.76 | 1.72 ± 0.82 | 1.27 ± 0.62 | < 0.001 |
Haemoglobin, g/L | 138.04 ± 24.14 | 140.10 ± 22.37 | 135.98 ± 25.64 | 0.003 |
Sodium, mmol/L | 141.00 ± 4.43 | 141.65 ± 3.99 | 140.36 ± 4.74 | < 0.001 |
Potassium, mmol/L | 3.94 ± 0.60 | 3.95 ± 0.56 | 3.94 ± 0.64 | 0.759 |
Albumin, g/l | 36.69 ± 4.54 | 37.81 ± 4.26 | 35.57 ± 4.54 | < 0.001 |
ALT, IU/L | 25.05 (16.70,42.30) | 24.20 (16.53,38.48) | 26.75 (16.73,49.80) | 0.009 |
AST, IU/L | 28.60 (20.10,43.28) | 27.20 (20.00,37.40) | 30.00 (20.53,53.33) | < 0.001 |
STB, μmol/L | 15.80 (10.40,24.60) | 15.10 (10.10,23.18) | 16.30 (10.73,25.70) | 0.053 |
CB, μmol/L | 7.10 (4.60,12.00) | 6.70 (4.40,10.90) | 7.40 (4.93,12.88) | 0.002 |
TC, mmol/L | 3.66 (3.00,4.21) | 3.67 (3.12,4.27) | 3.60 (2.94,4.15) | 0.016 |
TG, mmol/L | 1.12 (0.87,1.43) | 1.13 (0.86,1.51) | 1.10 (0.87,1.36) | 0.150 |
Cre, μmol/L | 103.50 (83.20,134.10) | 98.00 (81.60,123.85) | 109.30 (85.70,144.03) | < 0.001 |
Urea, mmol/L | 7.48 (5.72,10.26) | 6.93 (5.60,9.29) | 8.11 (5.91,11.63) | < 0.001 |
UA, μmol/L | 485.10 (376.48,586.00) | 474.20 (374.20,569.70) | 494.73 (379.60,604.38) | 0.063 |
eGFR, ml/min | 44.10 (32.29,56.69) | 47.20 (35.52,59.50) | 41.11 (28.30,53.70) | < 0.001 |
BNP, pg/ml | 1405.00 (877.48,2307.50) | 1240.00 (811.25,2067.50) | 1570.00 (952.25,2627.50) | < 0.001 |
lgBNP | 3.17 ± 0.28 | 3.13 ± 0.27 | 3.21 ± 0.29 | < 0.001 |
CRP, mg/L | 7.50 (3.02,21.78) | 3.02 (1.59,5.44) | 21.61 (12.50,47.80) | < 0.001 |
NLR | 3.31 (2.17,5.71) | 2.52 (1.78,3.55) | 4.89 (3.09,8.28) | < 0.001 |
C-NLR | 27.56 (7.88,95.15) | 7.90 (3.97,15.24) | 95.02 (51.16,238.38) | < 0.001 |
ECG parameters and Echocardiographic data | ||||
QRS wave, ms | 106.00 (94.00,128.00) | 106.00 (95.00,128.00) | 106.00 (93.00,128.00) | 0.257 |
LVEF, % | 43.00 (33.00,58.00) | 42.00 (32.00,58.00) | 44.00 (34.00,58.00) | 0.156 |
LVEF group | ||||
HFrEF | 523(43.9) | 278(46.6) | 245(41.1) | |
HFmrEF | 205(17.2) | 91(15.3) | 114(19.1) | 0.087 |
HFpEF | 464(38.9) | 227(38.1) | 237(39.8) | |
LVEDV, ml | 180.00 (126.00,238.00) | 186.00 (139.25,244.00) | 171.50 (118.00,230.75) | < 0.001 |
LVESV, ml | 105.00 (55.00,158.00) | 111.50 (61.00,164.00) | 96.00 (51.00,150.00) | 0.001 |
Treatment | ||||
ACEI/ARB/ARNI, % | 655(54.9) | 325(54.5) | 330(55.4) | 0.771 |
Beta-blocker, % | 592(49.7) | 312(52.3) | 280(47.0) | 0.064 |
CRT/D,% | 116(9.7) | 61(10.2) | 55(9.2) | 0.558 |
SGLT2i, % | 240(20.1) | 123(20.6) | 117(19.6) | 0.665 |
Diuretics, % | 983(82.5) | 486(81.5) | 497(83.4) | 0.402 |